TW200738281A - Bazedoxifene acetate formulations - Google Patents

Bazedoxifene acetate formulations

Info

Publication number: TW200738281A
Authority: TW; Taiwan
Prior art keywords: bazedoxifene acetate; acetate formulations; formulations; bazedoxifene; preparations
Prior art date: 2005-08-24

Application number

TW095130979A

Other languages

English (en)

Inventor

Syed M Shah

Christopher R Diorio

Eric C Ehrnsperger

Kadum A Ali

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-24

Filing date

2006-08-23

Publication date

2007-10-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37772333&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200738281(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-08-23 Application filed by Wyeth Corp filed Critical Wyeth Corp

2007-10-16 Publication of TW200738281A publication Critical patent/TW200738281A/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)

TW095130979A 2005-08-24 2006-08-23 Bazedoxifene acetate formulations TW200738281A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US71076105P	2005-08-24	2005-08-24

Publications (1)

Publication Number	Publication Date
TW200738281A true TW200738281A (en)	2007-10-16

Family

ID=37772333

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095130979A TW200738281A (en)	2005-08-24	2006-08-23	Bazedoxifene acetate formulations

Country Status (21)

Country	Link
US (1)	US7771744B2 (zh)
EP (1)	EP1919456A2 (zh)
JP (2)	JP2009506053A (zh)
KR (2)	KR20140088917A (zh)
CN (1)	CN101304731B (zh)
AR (1)	AR056471A1 (zh)
AU (1)	AU2006283121A1 (zh)
BR (1)	BRPI0615341A2 (zh)
CA (1)	CA2620174A1 (zh)
CR (1)	CR9746A (zh)
EC (1)	ECSP088214A (zh)
GT (1)	GT200600383A (zh)
IL (2)	IL189648A (zh)
MX (1)	MX2008002484A (zh)
NO (1)	NO20080991L (zh)
PE (1)	PE20070425A1 (zh)
RU (1)	RU2417084C2 (zh)
SV (1)	SV2008002825A (zh)
TW (1)	TW200738281A (zh)
WO (1)	WO2007024961A2 (zh)
ZA (1)	ZA200801742B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050227966A1 (en) *	2004-04-08	2005-10-13	Wyeth	Bazedoxifene acetate formulations
JP2009506053A (ja) *	2005-08-24	2009-02-12	ワイス	酢酸バゼドキシフェン製剤
CA2650498A1 (en) *	2006-03-31	2007-10-11	Rubicon Research Private Limited	Orally disintegrating tablets
US20100092564A1 (en) *	2006-12-21	2010-04-15	Jae Han Park	Composition of and Method for Preparing Orally Disintegrating Tablets
US20100016582A1 (en) *	2008-02-11	2010-01-21	Wyeth	Methods of converting polymorphic form b of bazedoxifene acetate to polymorphic form a of bazedoxifene acetate
ITMI20091109A1 (it)	2009-06-23	2010-12-24	Wyeth Corp	Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
WO2012072977A2 (en) *	2010-11-30	2012-06-07	Wista Laboratories Ltd.	Compound formulations
EP2471770A1 (en)	2010-12-28	2012-07-04	Sandoz Ag	Method of preparing polymorphic pure form A of bazedoxifene acetate
WO2013182169A1 (en)	2012-06-07	2013-12-12	Zentiva, K. S.	Process of preparation of an antioxidant-free polymorphically and chemically stable formulation of bazedoxifene acetate
WO2013182170A1 (en)	2012-06-07	2013-12-12	Zentiva, K. S.	Enhancement of dissolution rate from pharmaceutical composition comprising bazedoxifene acetate
CN103877581B (zh) *	2014-03-24	2016-03-02	江苏知原药业有限公司	一种性能优异的乙酸巴多昔芬缓释制剂
WO2018182205A1 (ko) *	2017-03-30	2018-10-04	한미약품 주식회사	바제독시펜 아세테이트를 함유하는 안정화된 약제학적 조성물
KR101940569B1 (ko) *	2017-05-24	2019-01-21	아주대학교산학협력단	바제독시펜 또는 이의 약학적으로 허용가능한 염을 포함하는 약학 조성물
CN112076163B (zh) *	2019-06-14	2023-06-20	四川科伦药物研究院有限公司	一种醋酸巴多昔芬片的药物组合物及其制备方法
CN111004165A (zh) *	2019-12-03	2020-04-14	南京正济医药研究有限公司	一种醋酸巴多昔芬晶型a的制备方法
CN112754999A (zh) *	2021-01-23	2021-05-07	郑州泰丰制药有限公司	一种醋酸巴多昔芬组合物及醋酸巴多昔芬薄膜衣片制备方法
CN113368075A (zh) *	2021-06-29	2021-09-10	郑州泰丰制药有限公司	一种醋酸巴多昔芬片及其制备方法
AU2022334112A1 (en) *	2021-08-23	2024-03-07	Oxygen Biotech LLC	Treatment of covid-19

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5686094A (en) *	1991-04-01	1997-11-11	Theratech, Inc.	Controlled release formulations for the treatment of xerostomia
HU223943B1 (hu) *	1995-06-22	2005-03-29	Akzo Nobel N.V.	Dezogesztrelt tartalmazó, szárazon granulált, sajtolt tabletták és előállításuk
US5998402A (en)	1996-04-19	1999-12-07	American Home Products Corporation	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en)	1998-05-15	2002-11-12	Wyeth	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
US20030004174A9 (en)	2000-02-17	2003-01-02	Armistead David M.	Kinase inhibitors
AR029538A1 (es) *	2000-07-06	2003-07-02	Wyeth Corp	Composiciones farmaceuticas de agentes estrogenicos
SE0104140D0 (sv)	2001-12-07	2001-12-07	Astrazeneca Ab	Novel Compounds
UA85374C2 (en) *	2002-06-13	2009-01-26	Уайт	bazedoxifene treatment regimen
CN1929835A (zh) *	2004-01-13	2007-03-14	惠氏公司	芳香酶抑制剂治疗－相关的骨质疏松症的治疗
RU2006132180A (ru)	2004-04-07	2008-05-20	Вайет (Us)	Кристаллический полиморф базедоксифен ацетата
PA8629201A1 (es)	2004-04-07	2005-11-25	Wyeth Corp	Polimorfo cristalino de acetato de bazedoxifeno
UA85703C2 (en) *	2004-04-07	2009-02-25	Уайет	Crystalline polymorph of bazedoxifene acetate
US20050227966A1 (en) *	2004-04-08	2005-10-13	Wyeth	Bazedoxifene acetate formulations
JP2009506053A (ja) *	2005-08-24	2009-02-12	ワイス	酢酸バゼドキシフェン製剤

2006
- 2006-08-23 JP JP2008528116A patent/JP2009506053A/ja not_active Withdrawn
- 2006-08-23 AR ARP060103666A patent/AR056471A1/es not_active Application Discontinuation
- 2006-08-23 WO PCT/US2006/032935 patent/WO2007024961A2/en not_active Ceased
- 2006-08-23 TW TW095130979A patent/TW200738281A/zh unknown
- 2006-08-23 BR BRPI0615341-0A patent/BRPI0615341A2/pt not_active Application Discontinuation
- 2006-08-23 RU RU2008107580/15A patent/RU2417084C2/ru active
- 2006-08-23 KR KR1020147017847A patent/KR20140088917A/ko not_active Ceased
- 2006-08-23 AU AU2006283121A patent/AU2006283121A1/en not_active Abandoned
- 2006-08-23 CA CA002620174A patent/CA2620174A1/en not_active Abandoned
- 2006-08-23 MX MX2008002484A patent/MX2008002484A/es active IP Right Grant
- 2006-08-23 PE PE2006001025A patent/PE20070425A1/es not_active Application Discontinuation
- 2006-08-23 EP EP06802170A patent/EP1919456A2/en not_active Withdrawn
- 2006-08-23 US US11/508,801 patent/US7771744B2/en active Active
- 2006-08-23 GT GT200600383A patent/GT200600383A/es unknown
- 2006-08-23 KR KR1020087006992A patent/KR101584674B1/ko active Active
- 2006-08-23 CN CN2006800394740A patent/CN101304731B/zh not_active Expired - Fee Related
2008
- 2008-02-19 CR CR9746A patent/CR9746A/es not_active Application Discontinuation
- 2008-02-21 IL IL189648A patent/IL189648A/en active IP Right Grant
- 2008-02-22 ZA ZA200801742A patent/ZA200801742B/xx unknown
- 2008-02-22 SV SV2008002825A patent/SV2008002825A/es not_active Application Discontinuation
- 2008-02-22 EC EC2008008214A patent/ECSP088214A/es unknown
- 2008-02-27 NO NO20080991A patent/NO20080991L/no not_active Application Discontinuation
2013
- 2013-06-11 JP JP2013122658A patent/JP2013209419A/ja active Pending
2014
- 2014-06-26 IL IL233392A patent/IL233392A/en active IP Right Grant

Also Published As

Publication number	Publication date
SV2008002825A (es)	2008-06-30
CN101304731B (zh)	2012-06-20
PE20070425A1 (es)	2007-07-02
JP2013209419A (ja)	2013-10-10
WO2007024961A3 (en)	2007-06-28
RU2417084C2 (ru)	2011-04-27
BRPI0615341A2 (pt)	2011-05-17
IL189648A (en)	2014-07-31
KR20140088917A (ko)	2014-07-11
IL189648A0 (en)	2008-08-07
US7771744B2 (en)	2010-08-10
NO20080991L (no)	2008-05-15
KR101584674B1 (ko)	2016-01-13
IL233392A0 (en)	2014-08-31
MX2008002484A (es)	2008-04-07
ZA200801742B (en)	2010-10-27
EP1919456A2 (en)	2008-05-14
CN101304731A (zh)	2008-11-12
RU2008107580A (ru)	2009-09-27
IL233392A (en)	2017-02-28
CR9746A (es)	2008-08-21
JP2009506053A (ja)	2009-02-12
AR056471A1 (es)	2007-10-10
GT200600383A (es)	2007-03-29
ECSP088214A (es)	2008-03-26
KR20080043853A (ko)	2008-05-19
WO2007024961A2 (en)	2007-03-01
CA2620174A1 (en)	2007-03-01
US20070048374A1 (en)	2007-03-01
AU2006283121A1 (en)	2007-03-01

Publication	Publication Date	Title
TW200738281A (en)	2007-10-16	Bazedoxifene acetate formulations
SG151331A1 (en)	2009-04-30	Crystalline polymorph of a bazedoxifene acetate
TW200719892A (en)	2007-06-01	Modulators of indoleamine 2,3-dioxygenase and methods of using the same
JO3181B1 (ar)	2018-03-08	مشتقات كمحول ثاني الكيل البايردينيل - أحادي الفينيل كأنزيم ثنائي استرات الفوسفود
PH12015501484A1 (en)	2017-06-05	Heteroaryl compounds and uses thereof
MX2009004746A (es)	2009-05-22	Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
MY148634A (en)	2013-05-15	Pyridazinone derivatives
MX2012007507A (es)	2012-08-01	Compuestos de heteroarilo y usos de los mismos.
UA83311C2 (en)	2008-06-25	3-aminocyclopentanecarboxamides as modulators of chemokine receptors
UA86055C2 (ru)	2009-03-25	Кристаллическая форма в базедоксифена ацетата
EP2129672A4 (en)	2009-12-09	ESTER AND CARBAMATE AZAADAMANTANE DERIVATIVES AND METHODS OF USE
TW200605863A (en)	2006-02-16	Bazedoxifene acetate formulations
SG158091A1 (en)	2010-01-29	Imidazoazepinone compounds
TW200716568A (en)	2007-05-01	1H-quinazoline-2,4-diones
WO2007072201A3 (en)	2007-10-04	3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2007062338A3 (en)	2007-11-15	Solid formulations
UA85703C2 (en)	2009-02-25	Crystalline polymorph of bazedoxifene acetate
WO2006031929A3 (en)	2006-06-01	Thiazolopyridine kinase inhibitors
TNSN08242A1 (en)	2009-10-30	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
TW200531693A (en)	2005-10-01	Prolonged-release diuretic compositions
WO2006097809A3 (en)	2007-04-26	Novel tyrosine derivatives
SI1893597T1 (sl)	2009-04-30	Ojaäśevalci ampa receptorja
UA83142C2 (en)	2008-06-10	3-aminocyclopentane carboxyamidine as modulators of chemokine receptors
UA92343C2 (en)	2010-10-25	Ampa receptor potentiators